EnVVeno Medical Corporation Insider Trading

NVNO

Last 12 months

Insiders sold 5K and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Dec 2024.

Net open-market

−5K

0 buys · 4 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Dec 2024

Dec 31, 2024

Get an email when NVNO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 11	Francis Duhay Director	Sold10b5-1 plan	11	$11.21	$123	0.5%	Form 4
Jun 11	Francis Duhay Director	Sold10b5-1 plan	140	$10.31	1K	5.6%	Form 4
Mar 12	Francis Duhay Director	Sold10b5-1 plan	140	$11.52	2K	5.3%	Form 4
Dec 11, 2025	Francis Duhay Director	Sold10b5-1 plan	4,900	$0.36	2K	5.0%	Form 4
Sep 15, 2025	Francis Duhay Director	Sold10b5-1 plan	4,900	$0.83	4K	4.8%	Form 4
Dec 31, 2024	Francis Duhay Director	Bought	81,433	$3.07	250K	389%	Form 4
Dec 31, 2024	Robert Gray Director	Bought	3,500	$2.94	10K	46%	Form 4
Dec 24, 2024	Sanjay Shrivastava Director	Bought	5,400	$2.90	16K	139%	Form 4
Dec 19, 2024	Matthew Jenusaitis Director	Bought	9,620	$2.53	24K	139%	Form 4
Dec 19, 2024	Robert Andrew Berman Chief Executive Officer	Bought	12,000	$2.55	31K	5.7%	Form 4

Sep 1110b5-1 plan
Francis Duhay
Director · sold 11 at $11.21
$123
0.5% of stake
Jun 1110b5-1 plan
Francis Duhay
Director · sold 140 at $10.31
1K
5.6% of stake
Mar 1210b5-1 plan
Francis Duhay
Director · sold 140 at $11.52
2K
5.3% of stake
Dec 11, 202510b5-1 plan
Francis Duhay
Director · sold 4,900 at $0.36
2K
5.0% of stake
Sep 15, 202510b5-1 plan
Francis Duhay
Director · sold 4,900 at $0.83
4K
4.8% of stake
Dec 31, 2024
Francis Duhay
Director · bought 81,433 at $3.07
250K
389% of stake
Dec 31, 2024
Robert Gray
Director · bought 3,500 at $2.94
10K
46% of stake
Dec 24, 2024
Sanjay Shrivastava
Director · bought 5,400 at $2.90
16K
139% of stake
Dec 19, 2024
Matthew Jenusaitis
Director · bought 9,620 at $2.53
24K
139% of stake
Dec 19, 2024
Robert Andrew Berman
Chief Executive Officer · bought 12,000 at $2.55
31K
5.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch NVNO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with NVNO

CompareIntrinsic value

ODYYOdyssey Group International Inc.

$0.01+0.00%10

RDGLVivos Inc.

$0.04-1.64%40

PAVMPAVmed Inc.

$1.66-8.79%25

MBOTMicrobot Medical Inc.

$1.14+4.59%25

SIGYSigyn Therapeutics Inc.

$0.03+0.00%30

GCTKGlucotrack Inc.

$0.40-12.66%25

FOFAFamily Office of America Inc.

$0.78+0.00%16

YBGJYubo International Biotech Limited

$0.01+0.00%0

Spot a number that looks wrong? Check it in NVNO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing NVNO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.